Sportradar Group AG engages in the provision of sports betting and entertainment products and services. It operates through the following segments: Rest of the World Betting, RoW Betting AV, and United StatesThe RoW Betting segment is involved in the betting and gaming solutions. The RoW Betting AV segment focuses on the live streaming solutions for online, mobile, and retail sports betting. The United States segment refers to the sports entertainment, betting, gaming, and sports solution. The company was founded by Carsten Marcus Koerl in 2001 and is headquartered in St. Gallen, Switzerland.

Candel Therapeutics, Inc. is a late clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.

Precision Optics Corp. engages in the design, development, manufacture, and selling of optical instruments. Its products include microprecision lenses and micro medical cameras, 3D endoscopes, and robotic surgery systems. The company was founded by Richard E. Forkey in December 1982 and is headquartered in Gardner, MA.

New Horizon Aircraft Ltd. is an advanced aerospace original equipment manufacturer, which engages in the designing and aiming to build a next generation hybrid electric vertical takeoff and landing aircraft for the regional air mobility market. The company was founded on March 11, 2022 and is headquartered in Lindsay, Canada.

Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery. Its cell replacement platform creates new cells and tissues with its pluripotent and progenitor cell technologies. The company's cell and drug delivery programs are based upon its proprietary HyStem cell and drug delivery matrix technology. It engages in the research and development of regenerative medicine or therapeutic products for advancement in the field of oncology, orthopedics, retinal and neurological diseases and disorders, blood and vascular system diseases and disorders, blood plasma volume expansion, diagnostic products for the early detection of cancer and hydrogel products that may be used in surgery and products for human embryonic stem cell research. The company was founded by Judith Segall, Hal Sternberg, Paul E. Segall and Harold D. Waitz on November 30, 1990 and is headquartered in Carlsbad, CA.

Mesa Royalty Trust owns overriding royalty interests in various oil and gas producing properties in the United States. It holds interests in properties located in the Hugoton field of Kansas; and the San Juan Basin field of Northwestern New Mexico and Southwestern Colorado. The company was founded in 1979 and is based in Houston, Texas.

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.

Tigo Energy, Inc. engages in the development and manufacture of smart hardware and software solutions. It focuses on enhancing safety, increasing energy yield, and lowering operating costs of residential, commercial, and utility-scale solar energy systems. The firm offers Module Level Power Electronics which provides solar panel power optimization, rapid shutdown and monitoring capabilities, and Energy Intelligence solutions which presents solar energy storage management capabilities. The company was founded on February 13, 2019 and is headquartered in Campbell, CA.

Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.